597
Views
19
CrossRef citations to date
0
Altmetric
Articles

Structure-based screening of inhibitors against KPC-2: designing potential drug candidates against multidrug-resistant bacteria

, , , , , & show all
Pages 741-750 | Received 10 Aug 2012, Accepted 23 Mar 2013, Published online: 19 Apr 2013

References

  • Akram, M., Shahid, M., & Khan, A. U. (2007). Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Annals of Clinical Microbiology and Antimicrobials, 6, 4.
  • Berendsen, H. J. C., Grigera, J. R., & Straatsma, T. P. (1987). The missing term in effective pair potentials. Journal of Physical Chemistry, 91, 6269–6271.
  • Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., & Alam, M. (2005). Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: A new threat to our antibiotic armamentarium. Archives of Internal Medicine, 165, 1430–1435.
  • Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., Sate, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4, 187–217.
  • Chowdhuri, S., Tan, M. L., & Ichiye, T. J. (2006). Dynamical properties of the soft sticky dipole–quadrupole–octupole water model: A molecular dynamics study. Journal of Chemical Physics, 125, 14451–14453.
  • Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log (N) method for Ewald sums in large systems. Journal of Chemical Physics, 98, 10089–10092.
  • Endimiani, A., Depasquale, J. M., Forero, S., Perez, F., Hujer, A. M., Roberts-Pollack, D., … Bonomo, R. A. (2009). Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: A new challenge to our healthcare system. Journal of Antimicrobial Chemotherapy, 64, 1102–1110.
  • Ewig, C. S., Berry, R., Dinur, U., Hill, J. R., & Hwang, M. J. (2001). Derivation of class II force fields. VIII. Derivation of a general quantum mechanical force field for organic compounds. Journal of Computational Chemistry, 22, 1782–1800.
  • Falagas, M. E., Karageorgopoulos, D. E., & Nordmann, P. (2011). Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiology, 6, 653–666.
  • Haque, S. F., Ali, S. Z., Tp, M., & Khan, A. U. (2012). Prevalence of plasmid mediated bla(TEM-1) and bla(CTX-M-15) type extended spectrum beta-lactamases in patients with sepsis. Asian Pacific Journal of Tropical Medicine, 5, 98–102.
  • Hasan, S., Danishuddin, M., Adil, M., Singh, K., Verma, P. K., & Khan, A. U. (2012). Efficacy of E. officinalis on the cariogenic properties of Streptococcus mutans: A novel and alternative approach to suppress quorum-sensing mechanism. PLoS ONE, 7, e40319. doi:10.1371/journal.pone.0040319.
  • Hess, B., Bekker, H., Berendsen, H. J. C., & Johannes, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18, 1463–1472.
  • Hoenigl, M., Valentin, T., Zarfel, G., Wuerstl,B., Leitner, E., Salzer, H. J., … Grisold, A. J. (2012). Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria. Antimicrobial Agents and Chemotherapy, 56, 2158–2161.
  • Irwin, J. J., & Shoichet, B. K. (2005). ZINC – A free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45, 177–182.
  • Jones, G., Willett, P., & Glen, R. C. (1995). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. Journal of Molecular Biology, 245, 43–53.
  • Ke, W., Bethel, C. R., Thomson, J. M., Bonomo, R. A., & van den Akker, F. (2007). Crystal structure of KPC-2: Insights into carbapenemase activity in class A β-lactamases. Biochemistry, 46, 5732–5740.
  • Khan, A. U., & Musharraf, A. (2004). Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Medical Science Monitor, 10, 598–602.
  • Kitchen, D. B., Decornez, H., Furr, J. R., & Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nature Reviews Drug Discovery, 3, 935–949.
  • Levitt, P. S., Papp-Wallace, K. M., Taracila, M. A., Hujer, A. M., Winkler, M. L., Smith, K. M., … Bonomo, R. A. (2012). Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: A mechanism for ceftazidime hydrolysis. Journal of Biological Chemistry, 287, 31783–31793.
  • Lindahl, E., Hess, B., van der Spoel, D. (2001). GROMACS 3.0: A package for molecular simulation and trajectory analysis. Journal of Molecular Modeling, 7, 306–317.
  • Moran, G. G., Venezia, S. N., Chmelnitsky, I., & Carmeli, Y. (2010). Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008. Antimicrobial Agents and Chemotherapy, 54, 2687–2691.
  • Naas, T., Nordmann, P., Vedel, G., & Poyart, C. (2005). Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrobial Agents and Chemotherapy, 49, 4423–4424.
  • Nagpal, I., Raj, I., Subbarao, N., Gourinath, S. (2012). Virtual screening, identification and in vitro testing of novel inhibitors of O-acetyl-L-serine sulfhydrylase of Entamoeba histolytica. PLoS ONE 7 e30305. doi:10.1371/journal.pone.0030305.
  • Nichols, D. A., Jaishankar, P., Larson, W., Smith, E., Liu, G., Beyrouthy, R., … Chen, Y. (2012). Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase. Journal of Medicinal Chemistry, 8, 2163–2172.
  • Nordmann, P., Cuzon, G., & Naas, T. (2009). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infectious Diseases, 9, 228–236.
  • Papp-Wallace, K. M., Bethel, C. R., Distler, A. M., Kasuboski, C., Taracila, M., & Bonomo, R. A. (2009). Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase. Antimicrobial Agents and Chemotherapy, 54, 890–897.
  • Papp-Wallace, K. M., Taracila, M., Hornick, J. M., Hujer, A. M., Hujer, K. M., Distler, A. M., … Bonomo, R. A. (2010). Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 β-Lactamase. Antimicrobial Agents and Chemotherapy, 54, 2867–2877.
  • Papp-Wallace, K. M., Taracila, M., Wallace, C. J., Hujer, K. M., Bethel, C. R., Hornick, J. M., & Bonomo, R. A. (2010). Elucidating the role of Trp105 in the KPC β-lactamase. Protein Science, 19, 1714–1727.
  • Queenan, A. M., Foleno, B., Gownley, C., Wira, E., & Bush, K. (2004). Effects of inoculum and β-Lactamase activity in AmpC- and Extended-Spectrum β-Lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology. Journal of Clinical Microbiology, 42, 269–275.
  • Sakkiah, S., Chandrasekaran, M., Lee, Y., Kim, S., & Lee, K. W. (2012). Molecular modeling study for conformational changes of Sirtuin 2 due to substrate and inhibitor binding. Journal of Biomolecular Structure and Dynamics, 30, 235–254.
  • Shoichet, B. K. (2004). Virtual screening of chemical libraries. Nature, 432, 862–865.
  • Tan, Q., Ogawa, A. M., Painter, R. E., Park, Y. W., Young, K., & DiNinno, F. P. (2010). 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: First boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity. Bioorganic & Medicinal Chemistry Letters, 20, 2622–2624.
  • Thomson, J. M., & Bonomo, R. A. (2005). The threat of antibiotic resistance in Gram-negative pathogenic bacteria: Beta-Lactams in peril. Current Opinion in Microbiology, 8, 518–524.
  • Tronrud, D. E. (1992). Conjugate-direction minimization: An improved method for the refinement of macromolecules. Acta Crystallographica, 48, 912–916.
  • Van der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computaional Chemistry, 26, 1701–1718.
  • Villegas, M. V., Lolans, K., Correa, A., Suarez, C. J., Lopez, J. A., Vallejo, M., & Quinn, J. P. (2006). First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrobial Agents and Chemotherapy, 50, 2880–2882.
  • Wade, R. C., & Goodford, P. J. (1989). The role of hydrogen-bonds in drug binding. Progress in Clinical and Biological Research, 289, 433–444.
  • Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: A program to generate schematic diagrams of protein–ligand interactions. Protein Engineering, 8, 127–134.
  • Wang, R., Lai, L., & Wang, S. (2002). Further development and validation of empirical scoring functions for structure-based binding affinity prediction. Journal of Computer-Aided Molecular Design, 16, 11–26.
  • Woodford, N., Zhang, J., Warner, M., Kaufmann, M. E., Matos, J., Macdonald, A., … Livermore, D. M. (2008). Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom. Journal of Antimicrobial Chemotherapy, 62, 1261–1264.
  • Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., … Tenover, F. C. (2001). Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 45, 1151–1161.
  • Zhang, R., Zhou, H. W., Cai, J. C., & Chen, G. X. (2007). Plasmid-mediated carbapenem-hydrolyzing-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. Journal of Antimicrobial Chemotherapy, 59, 574–576.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.